T1	Concept 10 16	RNAseq
T2	Action 17 27	identified
T3	Concept 31 42	RNA viruses
R1	subject Arg1:T2 Arg2:T1	
R2	target Arg1:T2 Arg2:T3	
T4	Concept 28 30	10
R3	in-context Arg1:T3 Arg2:T4	
T5	Action 57 73	have established
R4	in-context Arg1:T5 Arg2:T3	
T6	Concept 74 87	pathogenicity
R5	target Arg1:T5 Arg2:T6	
T7	Concept 95 100	lungs
R6	in-place Arg1:T6 Arg2:T7	
T8	Concept 110 127	RNA intermediates
R7	target Arg1:T5 Arg2:T8	
T9	Concept 136 147	DNA viruses
T10	Concept 131 135	five
R8	in-context Arg1:T9 Arg2:T10	
T11	Concept 168 191	pulmonary pathogenicity
R9	has-property Arg1:T9 Arg2:T11	
A1	Uncertain T11
T12	Concept 192 198	DNAseq
T13	Action 199 209	identified
R10	subject Arg1:T13 Arg2:T12	
T14	Concept 214 221	genomes
R11	target Arg1:T13 Arg2:T14	
T15	Concept 241 252	DNA viruses
T16	Concept 236 240	five
T17	Reference 225 235	these same
R12	in-context Arg1:T15 Arg2:T16	
R13	in-context Arg1:T16 Arg2:T17	
T18	Concept 269 275	others
T19	Concept 264 268	five
R14	in-context Arg1:T19 Arg2:T17	
R15	in-context Arg1:T18 Arg2:T19	
T20	Action 276 285	including
T21	Concept 286 289	CMV
T22	Concept 294 299	HHV-6
T24	Concept 333 344	pneumonitis
R19	subject Arg1:T20 Arg2:T18	
R20	target Arg1:T20 Arg2:T21	
R21	target Arg1:T20 Arg2:T22	
T23	Action 307 327	have been associated
R16	subject Arg1:T23 Arg2:T22	
R17	subject Arg1:T23 Arg2:T21	
R18	target Arg1:T23 Arg2:T24	
T27	Concept 378 388	expression
T28	Concept 368 377	increased
A2	Emphasized T28
R23	has-property Arg1:T27 Arg2:T28	
T29	Concept 392 400	patients
R25	in-place Arg1:T27 Arg2:T29	
T30	Concept 416 430	LRTI pathogens
R26	has-property Arg1:T29 Arg2:T30	
T31	Concept 438 443	those
R27	in-context Arg1:T31 Arg2:T29	
T32	Concept 444 451	without
R28	has-property Arg1:T31 Arg2:T32	
R29	in-context Arg1:T32 Arg2:T30	
T34	Concept 795 816	respiratory pathogens
T35	Concept 848 858	expression
T36	Concept 838 847	increased
R30	has-property Arg1:T35 Arg2:T36	
T38	Concept 783 791	presence
R33	in-context Arg1:T38 Arg2:T34	
T39	Action 821 834	characterized
R34	subject Arg1:T39 Arg2:T38	
R35	target Arg1:T39 Arg2:T35	
T40	Concept 862 888	host immune response genes
T41	Concept 899 925	airway microbial diversity
R36	in-context Arg1:T35 Arg2:T40	
R37	in-context Arg1:T35 Arg2:T41	
A3	Diminished T41
T42	Action 457 468	benchmarked
T43	Concept 506 518	care testing
T44	Concept 481 502	conventional standard
T45	Concept 548 564	study enrollment
T46	Concept 566 570	mNGS
T47	Action 571 583	demonstrated
T48	Concept 589 600	sensitivity
T49	Concept 584 588	100%
R41	in-context Arg1:T48 Arg2:T49	
R42	subject Arg1:T47 Arg2:T46	
R43	target Arg1:T47 Arg2:T48	
T50	Concept 605 624	microbial detection
R44	in-context Arg1:T48 Arg2:T50	
T51	Action 639 653	identification
T53	Concept 671 676	viral
T54	Concept 667 670	new
R47	has-property Arg1:T53 Arg2:T54	
R48	target Arg1:T51 Arg2:T53	
A4	Uncertain T53
T55	Concept 681 700	bacterial pathogens
A5	Uncertain T55
R49	target Arg1:T51 Arg2:T55	
T56	Concept 720 728	subjects
R50	in-place Arg1:T51 Arg2:T56	
T57	Concept 704 719	six of 15 (40%)
R51	in-context Arg1:T56 Arg2:T57	
T58	Concept 753 760	testing
A6	Negated T58
R52	has-property Arg1:T56 Arg2:T58	
R40	target Arg1:T42 Arg2:T44	
R38	in-context Arg1:T44 Arg2:T43	
R39	in-time Arg1:T43 Arg2:T45	
R53	subject Arg1:T42 Arg2:T46	
R31	causes Arg1:T46 Arg2:T51	
